Skip to content

Veritas Investment Management (UK) Ltd

Follow

13F filer, CIK 1577920, LONDON, United Kingdom

Veritas Investment Management (UK) Ltd reported $0 across 1 holding for the quarter ended 2022-03-31, in a 13F-HR filed 2022-05-16.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001567619-22-010771

Period
2022-03-31
Reported value
$0
Holdings
1
Top 10 weight
New
1
Sold out
36

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
UNHexited-99,122-$49.8M
TMOexited-66,719-$44.5M
LABORATORY CRP OF AMER HLDGSexited-126,965-$39.9M
ACNexited-94,026-$39M
FNVexited-220,601-$38.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2022

Share positions as resolved from 13F-HR 0001567619-22-010771, largest first. % of portfolio is the value over $0, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
00Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: 0 shares 0$0newValue filed as zero, left out of ratios.Amount filed as zero, left out of ratios.

Sold out in Q1 2022

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
UNHUNITEDHEALTH GROUP INC99,122$49.8Mshares
TMOTHERMO FISHER SCIENTIFIC INC66,719$44.5Mshares
LABORATORY CRP OF AMER HLDGSLABORATORY CRP OF AMER HLDGS126,965$39.9Mshares
ACNACCENTURE PLC IRELAND94,026$39Mshares
FNVFRANCO NEV CORP220,601$38.6Mshares
CERNER CORPCERNER CORP404,074$37.5Mshares
MAMASTERCARD INCORPORATED92,977$33.4Mshares
TSCOTRACTOR SUPPLY CO138,060$32.9Mshares
MSFTMICROSOFT CORP97,309$32.7Mshares
MRSHMARSH & MCLENNAN COS INC177,594$30.9Mshares
FISVFISERV INC273,695$28.4Mshares
HASHASBRO INC263,029$26.8Mshares
ADPAUTOMATIC DATA PROCESSING IN105,053$25.9Mshares
BRBROADRIDGE FINL SOLUTIONS IN125,360$22.9Mshares
APHAMPHENOL CORP251,890$22Mshares
SNPSSYNOPSYS INC57,560$21.2Mshares
AVYAVERY DENNISON CORP94,101$20.4Mshares
TSMTAIWAN SEMICONDUCTOR MANUFAC166,567$20Mshares
ALGNALIGN TECHNOLOGY INC27,673$18.2Mshares
INTUINTUIT27,181$17.5Mshares
AMZNAMAZON COM INC4,279$14.3Mshares
GOOGALPHABET INC4,850$14Mshares
GOOGLALPHABET INC2,668$7.73Mshares
BRK-BBERKSHIRE HATHAWAY INC DEL16,886$5.05Mshares
JARDINE MATHESON HOLDINGSJARDINE MATHESON HOLDINGS32,600$1.79Mshares
AAPLAPPLE INC3,779$671Kshares
BACBANK OF AMER CORP12,500$556Kshares
HCAHCA HEALTHCARE INC1,600$411Kshares
BROOKFIELD ASSET MANAGEMENT…BROOKFIELD ASSET MANAGEMENT IN4,326$330Kshares
MDTMEDTRONIC PLC1,761$182Kshares
MOALTRIA GROUP INC1,500$71Kshares
JPMJPMORGAN CHASE & CO380$60Kshares
CBCHUBB LIMITED108$21Kshares
WFCWELLS FARGO & CO350$17Kshares
BBUBROOKFIELD BUSINESS PARTNERS L57$3Kshares
INTELLECT NEUROSCIENCESINTELLECT NEUROSCIENCES37$0shares

How Q1 2022 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001567619-22-010771 base2022-05-16acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001567619-22-010771 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001567619-22-003384 Quarter ended 2021-12-312022-02-11acceptance time not in the bulk data set
13F-HR 0001567619-21-019958 Quarter ended 2021-09-302021-11-12acceptance time not in the bulk data set
13F-HR 0001567619-21-014474 Quarter ended 2021-06-302021-08-05acceptance time not in the bulk data set
13F-HR 0001567619-21-010026 Quarter ended 2021-03-312021-05-14acceptance time not in the bulk data set
13F-HR 0001567619-21-002862 Quarter ended 2020-12-312021-02-11acceptance time not in the bulk data set
13F-HR 0001567619-20-018477 Quarter ended 2020-09-302020-11-02acceptance time not in the bulk data set
13F-HR 0001567619-20-014373 Quarter ended 2020-06-302020-08-06acceptance time not in the bulk data set
13F-HR 0001567619-20-009099 Quarter ended 2020-03-312020-05-06acceptance time not in the bulk data set
13F-HR/A 0001567619-20-009097 Quarter ended 2019-12-312020-05-06acceptance time not in the bulk data set
13F-HR 0001567619-20-001736 Quarter ended 2019-12-312020-01-30acceptance time not in the bulk data set
13F-HR 0001567619-19-020426 Quarter ended 2019-09-302019-11-05acceptance time not in the bulk data set
13F-HR 0001567619-19-015767 Quarter ended 2019-06-302019-08-05acceptance time not in the bulk data set
13F-HR 0001567619-19-009947 Quarter ended 2019-03-312019-05-07acceptance time not in the bulk data set
13F-HR 0001567619-19-002167 Quarter ended 2018-12-312019-02-01acceptance time not in the bulk data set
13F-HR 0001567619-18-005205 Quarter ended 2018-09-302018-11-07acceptance time not in the bulk data set
13F-HR 0001140361-18-034693 Quarter ended 2018-06-302018-08-01acceptance time not in the bulk data set
13F-HR 0001140361-18-020818 Quarter ended 2018-03-312018-05-01acceptance time not in the bulk data set
13F-HR 0001140361-18-005102 Quarter ended 2017-12-312018-02-06acceptance time not in the bulk data set
13F-HR 0001140361-17-041122 Quarter ended 2017-09-302017-11-06acceptance time not in the bulk data set
13F-HR 0001140361-17-030853 Quarter ended 2017-06-302017-08-09acceptance time not in the bulk data set
13F-HR 0001140361-17-020256 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0001140361-17-003636 Quarter ended 2016-12-312017-01-31acceptance time not in the bulk data set
13F-HR 0001140361-16-085714 Quarter ended 2016-09-302016-11-10acceptance time not in the bulk data set
13F-HR 0001140361-16-075421 Quarter ended 2016-06-302016-08-09acceptance time not in the bulk data set
13F-HR 0001140361-16-062949 Quarter ended 2016-03-312016-05-03acceptance time not in the bulk data set
13F-HR 0001140361-16-049947 Quarter ended 2015-12-312016-02-03acceptance time not in the bulk data set
13F-HR 0001140361-15-041002 Quarter ended 2015-09-302015-11-13acceptance time not in the bulk data set
13F-HR 0001140361-15-031526 Quarter ended 2015-06-302015-08-13acceptance time not in the bulk data set
13F-HR 0001140361-15-018270 Quarter ended 2015-03-312015-05-07acceptance time not in the bulk data set
13F-HR 0001140361-15-004420 Quarter ended 2014-12-312015-02-06acceptance time not in the bulk data set
13F-HR 0001140361-14-039635 Quarter ended 2014-09-302014-10-31acceptance time not in the bulk data set
13F-HR 0001140361-14-031668 Quarter ended 2014-06-302014-08-11acceptance time not in the bulk data set
13F-HR 0001140361-14-021256 Quarter ended 2014-03-312014-05-15acceptance time not in the bulk data set
13F-HR 0001140361-14-006175 Quarter ended 2013-12-312014-02-12acceptance time not in the bulk data set
13F-HR 0001140361-13-042014 Quarter ended 2013-09-302013-11-13acceptance time not in the bulk data set
13F-HR 0001140361-13-032534 Quarter ended 2013-06-302013-08-14acceptance time not in the bulk data set